Open AccessS198: BET INHIBITOR PELABRESIB (CPI‐0610) COMBINED WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS — JAK INHIBITOR‐NAÏVE OR WITH SUBOPTIMAL RESPONSE TO RUXOLITINIB — PRELIMINARY DATA FROM THE MANIFEST STUDY
Author(s) -
Mascarenhas J.,
Kremyanskaya M.,
Patriarca A.,
Harrison C.,
Bose P.,
Rampal R. K.,
Palandri F,
Devos T.,
Passamonti F.,
Hobbs G.,
Talpaz M.,
Vannucchi A.,
Kiladjian J.J.,
Verstovsek S.,
Hoffman R.,
Salama M. E.,
Chen D.,
Taverna P.,
Chang A.,
Colak G.,
Klein S.,
Gupta V.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843684.97625.7e
Subject(s) - ruxolitinib , medicine , myelofibrosis , myeloproliferative neoplasm , oncology , bone marrow